|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 6 of 11 found articles
| Title: |
Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study |
| Author: |
Han, Baohui Li, Kai Wang, Qiming Zhao, Yizhuo Zhang, Li Shi, Jianhua Wang, Zhehai Cheng, Yin He, Jianxing Shi, Yuankai Chen, Weiqiang Wang, Xiuwen Luo, Yi Nan, Kejun Jin, Faguang Li, Baolan Chen, Yinlan Zhou, Jianying Wang, Donglin |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 18 (2017) nr. S1 pages 1 p. |
| Year: |
2017 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 6 of 11 found articles
| << previous | next >> |